Anti-BTK antibody-coupled liposomes represent a novel therapeutic approach targeting B cell receptor (BCR) signaling in B cell malignancies. These liposomes can deliver cytotoxic drugs or other therapeutic agents specifically to B cells, exploiting the overexpression of Bruton's tyrosine kinase (BTK) in cancerous B cells. By coupling anti-BTK antibodies to liposomes, this strategy allows for selective targeting of malignant B cells while sparing healthy cells, potentially reducing side effects.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-0393 | Hi-Affi™ Rabbit Anti-BTK Recombinant Antibody (clone DS393AB) | ICC, WB | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY48. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.